Back to Agenda
Impact of Human Factors on the Development of Combination Products
Session Chair(s)
![Muriel Didier](/_Images/member/Generic_Image_Missing-Profile.jpg)
Muriel Didier
Human Factors Group Head
Novartis, Switzerland
Impact of Human Factors on the Development of Combination Products
Speaker(s)
Panel Discussion
Chin-Wei Soo, DrSc
Genentech, A Member of the Roche Group, United States
Global Regulatory Head, PTR Devices and Combination Products
![Lee Wood, MSc](/_Images/member/Generic_Image_Missing-Profile.jpg)
Panel Discussion
Lee Wood, MSc
MedHF, Switzerland
Co-Founder and CEO
![Andrew Warrington](/_Images/member/Generic_Image_Missing-Profile.jpg)
Panel Discussion
Andrew Warrington
DayOneLab, Switzerland
![Edward James Oakeley, PhD](/_Images/member/Generic_Image_Missing-Profile.jpg)
Panel Discussion
Edward James Oakeley, PhD
Patient Advocate, Switzerland
Patient Advocate
Have an account?